Menu
Recruiting NCT04505579

The Tether™ - Vertebral Body Tethering System Post Approval Study

Observational Scoliosis Idiopathic

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Anterior Vertebral Body Tethering.
Who it may be relevant to
Registry conditions: Scoliosis Idiopathic. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study is an opportunity to provide continued reasonable assurance of the safety and probable benefit of The Tether HUD. The study will collect long term safety and efficacy information from patients who have had their idiopathic scoliosis treated via anterior vertebral body tethering (AVBT) with The Tether.

Detailed description

While spinal fusion remains the standard surgical treatment for progressive idiopathic scoliosis, concerns about the long-term effects of spinal fusion have led to the investigation of growth-modulation techniques. Anterior Vertebral Body Tethering (AVBT) is one such technique that utilizes growth modulation to remodel the shape of the vertebra and straighten scoliotic curves in skeletally immature individuals. In this technique, screws are inserted at each vertebral level for the length of the convex side of the curve. A strong cord is connected through the screw tulip heads and used to initially straighten the curve as each level is fixed with a set screw. Following surgery and during the growth period the spine begins to remodel according to the Hueter-Volkmann Law, bone growth is relatively inhibited in areas of increased pressure (convex or tethered side) and relatively stimulated in areas of decreased pressure or tension (concave side). Following this principle, AVBT has been shown to alter spinal growth with the potential to correct scoliosis while maintaining spine flexibility.

The objective of the study is to assess the ongoing safety and probable benefit of The Tether HUD which was approved by the FDA under an HDE. Subject enrollment and data collection will be managed by the Harms Study Group (HSG) and Setting Scoliosis Straight Foundation (SSSF) Registry. Institutions that are HSG members or affiliates, with Investigators/surgeons that are trained and approved to perform surgeries with The Tether, will participate in the registry. Ten sites from this group will be identified as study sites specific to this Tether post-approval study (PAS). Consecutive subjects from these sites, that meet the eligibility criteria of this study, will be flagged in the registry as the PAS cohort and the study endpoints will be assessed across this population.

Interventions

  • Device Anterior Vertebral Body Tethering
    Anterior Vertebral Body Tethering (AVBT) is a technique that utilizes growth modulation to remodel the shape of the vertebra and straighten scoliotic curves in skeletally immature individuals. In this technique, screws are inserted at each vertebral level for the length of the convex side of the curve. A strong cord is connected through the screw tulip heads and used to initially straighten the curve as each level is fixed with a set screw. Following surgery and during the growth period the spin

Primary outcome measures

  • Rate of SAEs and device- &/or procedure-related AEs [Time frame: AVBT surgery to five year post-op]
  • Percentage of subjects with maintenance of the major Cobb angle less than or equal to 40 degrees at 60 months post-surgery [Time frame: AVBT surgery to five year post-op]
Secondary outcome measures (11)
  • Adverse Events [Time frame: AVBT surgery to five year post-op]
  • Reoperation [Time frame: AVBT surgery to five year post-op]
  • Number of participants with new curves that develop above or below the tethered portion of the spine. [Time frame: AVBT surgery to five year post-op]
  • Number of participants with secondary curves that progress to the point of clinical significance. [Time frame: AVBT surgery to five year post-op]
  • Number of participants with device integrity failures including cord breakage and screw migration. [Time frame: AVBT surgery to five year post-op]
  • Mean (SD) and distributions of sagittal balance (mm) from pre-op through last visit [Time frame: Baseline to five year post-op]
  • Mean (SD) and distributions of lumbar lordosis (degrees) from pre-op through last visit. [Time frame: Baseline to five year post-op]
  • Mean score of Scoliosis Research Society 22r Patient Questionnaire [Time frame: Baseline to five year post-op]
  • Number of participants with compromised lung function [Time frame: Baseline to five year post-op]
  • Measurement (degrees rotation) of trunk shape by scoliometer device. Mean (SD) [min, max] will be reported. [Time frame: Baseline to five year post-op]
  • Trunk flexibility as determined by distance (cm) of flexion and lateral bend using fingertip to floor method. [Time frame: Baseline to five year post-op]

Eligibility criteria

Inclusion criteria

  • Diagnosis of progressive idiopathic scoliosis
  • Skeletally immature, based on both Risser (<5) and Sanders (<8) assessments
  • Major Cobb angle ≥30° and ≤65°
  • Osseous structure dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging
  • Failed or intolerant to bracing

Exclusion criteria

  • Presence of any systemic infection, local infection, or skin compromise at the surgical site
  • Prior spinal surgery at the level(s) to be treated
  • Documented poor bone quality, defined as a T-score -1.5 or less
  • Any other medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, and patient's unwillingness or inability to cooperate with post-operative care instructions
  • Unwillingness, inability, or living situation (e.g. custody arrangements, homelessness, detention) that would preclude ability to return to the study site for follow-up visits as described in protocol and Informed Consent
  • Unwillingness to sign Informed Consent Form and participate in study procedures

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 10 centers
  • Rady Children's Hospital — San Diego
  • Children's Hospital Colorado — Aurora
  • Nemours Children's Health — Jacksonville
  • Children's Healthcare of Atlanta — Atlanta
  • Ochsner Health — New Orleans
  • Mayo Clinic — Rochester
  • University of Missouri - Columbia — Columbia
  • Mount Sinai — New York
  • … and 2 more centers

Identifiers

NCT: NCT04505579 · RAU2019-40S

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗